Home › Funds › Two Sigma Investments › INBX
Two Sigma Investments position in INBX
INHIBRX BIOSCIENCES INC · Health Care
Latest position (Q1 2024)78.40K sh
Reported value held$2.74M
Portfolio Weight0.01%
First reportedQ1 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 57.77K | $1.29M | New |
| Q2 2022 | 124.22K | $1.41M | Add |
| Q3 2022 | 163.49K | $2.94M | Add |
| Q4 2022 | 246.00K | $6.06M | Add |
| Q1 2023 | 335.80K | $6.34M | Add |
| Q2 2023 | 260.42K | $6.76M | Reduce |
| Q3 2023 | 207.67K | $3.81M | Reduce |
| Q4 2023 | 7.90K | $300.20K | Reduce |
| Q1 2024 | 78.40K | $2.74M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding INBX
- Morgan Stanley 1.31M sh · $123.94M · Q2 2026
- Viking Global Investors 1.12M sh · $106.49M · Q2 2026
- Bank of America Corp 841.14K sh · $79.70M · Q2 2026
- BlackRock Inc 825.97K sh · $78.26M · Q2 2026
- Vanguard Group 623.08K sh · $49.22M · Q4 2025
- Capital Research Global Investors 363.05K sh · $34.40M · Q2 2026
- Geode Capital Management 256.18K sh · $24.28M · Q2 2026
- Millennium Management 147.20K sh · $13.95M · Q2 2026
- Northern Trust Corp 100.96K sh · $9.57M · Q2 2026
- Norges Bank Investment Management 90.30K sh · $8.56M · Q2 2026
- Citigroup Inc 75.72K sh · $7.17M · Q2 2026
- Goldman Sachs Group 66.50K sh · $6.30M · Q2 2026